Twist Bioscience Corporation
TWST
$39.96
$0.842.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.85% | 27.69% | 25.37% | 21.79% | 21.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.85% | 27.69% | 25.37% | 21.79% | 21.58% |
| Cost of Revenue | 8.60% | 15.60% | 21.47% | 28.09% | 38.42% |
| Gross Profit | 56.81% | 48.61% | 31.57% | 12.84% | -0.19% |
| SG&A Expenses | 10.73% | 15.11% | 8.21% | -1.09% | -1.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.62% | 8.16% | 6.14% | 1.25% | 2.79% |
| Operating Income | 20.26% | 14.98% | 14.59% | 18.66% | 14.19% |
| Income Before Tax | 3.83% | -2.31% | -5.80% | 9.66% | 4.41% |
| Income Tax Expenses | -55.10% | -51.39% | -73.95% | -3.35% | 1,608.57% |
| Earnings from Continuing Operations | 4.13% | -2.01% | -5.17% | 9.63% | 3.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.13% | -2.01% | -5.17% | 9.63% | 3.89% |
| EBIT | 20.26% | 14.98% | 14.59% | 18.66% | 14.19% |
| EBITDA | 21.46% | 17.61% | 19.98% | 25.65% | 21.12% |
| EPS Basic | 6.07% | -0.07% | -3.16% | 11.09% | 6.63% |
| Normalized Basic EPS | 21.84% | 17.10% | 18.19% | 23.55% | 20.75% |
| EPS Diluted | 5.99% | -0.14% | -3.23% | 11.13% | 6.74% |
| Normalized Diluted EPS | 21.84% | 17.10% | 18.19% | 23.55% | 20.75% |
| Average Basic Shares Outstanding | 2.21% | 1.95% | 1.84% | 1.69% | 2.75% |
| Average Diluted Shares Outstanding | 2.21% | 1.95% | 1.84% | 1.69% | 2.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
